Cancer-derived extracellular vesicles (EVs) promote tumorigenesis, premetastatic niche formation, and metastasis via their protein cargo. However, the proteins packaged by patient tumors into EVs cannot be determined in vivo because of the presence of EVs derived from other tissues. We therefore developed a cross-species proteomic method to quantify the human tumor-derived proteome of plasma EVs produced by patient-derived xenografts of four cancer types. Proteomic profiling revealed individualized packaging of novel protein cargo, and machine learning accurately classified the type of the underlying tumor.

Original languageEnglish
Article number100476
JournalMolecular and Cellular Proteomics
Issue number1
StatePublished - Jan 2023


Dive into the research topics of 'Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin'. Together they form a unique fingerprint.

Cite this